Crescent Biopharma Advances Clinical Trials
Enrollment is progressing in the global ASCEND Phase 1/2 trial of CR-001 and the company extended its cash runway into 2028.
View filing at SEC.gov →1 most recent filing and news item mentioning CBIO. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/CBIO/news?limit=20"
Pull CBIO filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayEnrollment is progressing in the global ASCEND Phase 1/2 trial of CR-001 and the company extended its cash runway into 2028.
View filing at SEC.gov →